Arun K. Garg - Autologous Blood Concentrates

23. Malhotra A, Pelletier MH, Yu Y, Walsh WR. Can platelet-rich plasma (PRP) improve bone healing? A comparison between the theory and experimental outcomes. Arch Orthop Trauma Surg 2013;133:153–165.

24. Ross R, Glomset J, Kariya B, Harker L. A platelet-dependent serum factor that stimulates the proliferation of arterial smooth muscle cells in vitro. Proc Natl Acad Sci U S A 1974;71:1207–1210.

25. Witte LD, Kaplan KL, Nossel HL, Lages BA, Weiss HJ, Goodman DS. Studies of the release from human platelets of the growth factor for cultured human arterial smooth muscle cells. Circ Res 1978;42:402–409.

26. Ross R, Nist C, Kariya B, Rivest MJ, Raines E, Callis J. Physiological quiescence in plasma-derived serum: Influence of platelet-derived growth factor on cell growth in culture. J Cell Physiol 1978;97(3 pt 2 suppl 1):497–508.

27. Kaplan DR, Chao FC, Stiles CD, Antoniades HN, Scher CD. Platelet alpha granules contain a growth factor for fibroblasts. Blood 1979;53:1043–1052.

28. Assoian RK, Komoriya A, Meyers CA, Miller DM, Sporn MB. Transforming growth factor-beta in human platelets. Identification of a major storage site, purification, and characterization. J Biol Chem 1983;258:7155–7160.

29. Derynck R. Transforming growth factor-alpha: Structure and biological activities. J Cell Biochem 1986;32:293–304.

30. Karey KP, Marquardt H, Sirbasku DA. Human platelet-derived mitogens. I. Identification of insulinlike growth factors I and II by purification and N alpha amino acid sequence analysis. Blood 1989;74:1084–1092.

31. Karey KP, Sirbasku DA. Human platelet-derived mitogens. II. Subcellular localization of insulinlike growth factor I to the alpha-granule and release in response to thrombin. Blood 1989;74:1093–1100.

32. Brunner G, Nguyen H, Gabrilove J, Rifkin DB, Wilson EL. Basic fibroblast growth factor expression in human bone marrow and peripheral blood cells. Blood 1993;81:631–638.

33. Dooley DC, Oppenlander BK, Spurgin P, et al. Basic fibroblast growth factor and epidermal growth factor downmodulate the growth of hematopoietic cells in long-term stromal cultures. J Cell Physiol 1995;165:386–397.

34. Banks RE, Forbes MA, Kinsey SE, et al. Release of the angiogenic cytokine vascular endothelial growth factor (VEGF) from platelets: Significance for VEGF measurements and cancer biology. Br J Cancer 1998;77:956–964.

35. Hormbrey E, Gillespie P, Turner K, et al. A critical review of vascular endothelial growth factor (VEGF) analysis in peripheral blood: Is the current literature meaningful? Clin Exp Metastasis 2002;19:651–663.

36. Sánchez M, Anitua E, Andia I. Poor standardization in platelet-rich therapies hampers advancement. Arthroscopy 2010;26:725–726.

37. Taylor DW, Petrera M, Hendry M, Theodoropoulos JS. A systematic review of the use of platelet-rich plasma in sports medicine as a new treatment for tendon and ligament injuries. Clin J Sport Med 2011;21:344–352.

38. Moraes VY, Lenza M, Tamaoki MJ, Faloppa F, Belloti JC. Platelet-rich therapies for musculoskeletal soft tissue injuries. Cochrane Database Syst Rev 2014;4:CD010071.

39. Kim TH, Kim SH, Sándor GK, Kim YD. Comparison of platelet-rich plasma (PRP), platelet-rich fibrin (PRF), and concentrated growth factor (CGF) in rabbit-skull defect healing. Arch Oral Biol 2014;59:550–558.

40. Sandrey MA. Autologous growth factor injections in chronic tendinopathy. J Athl Train 2014;49:428–430.

41. Stellos K, Langer H, Daub K, et al. Platelet-derived stromal cell-derived factor-1 regulates adhesion and promotes differentiation of human CD34+ cells to endothelial progenitor cells. Circulation 2008;117:206–215.

42. Okabe K, Yamada Y, Ito K, Kohgo T, Yoshimi R, Ueda M. Injectable soft-tissue augmentation by tissue engineering and regenerative medicine with human mesenchymal stromal cells, platelet-rich plasma and hyaluronic acid scaffolds. Cytotherapy 2009;11:307–316.

43. Kon E, Filardo G, Di Martino A, Marcacci M. Platelet-rich plasma (PRP) to treat sports injuries: Evidence to support its use. Knee Surg Sports Traumatol Arthrosc 2011;19:516–527.

44. Wu CC, Chen WH, Zao B, et al. Regenerative potentials of platelet-rich plasma enhanced by collagen in retrieving pro-inflammatory cytokine-inhibited chondrogenesis. Biomaterials 2011;32:5847–5854.

45. Bava ED, Barber FA. Platelet-rich plasma products in sports medicine. Phys Sportsmed 2011;39:94–99.

46. Torricelli P, Fini M, Filardo G, et al. Regenerative medicine for the treatment of musculoskeletal overuse injuries in competition horses. Int Orthop 2011;35:1569–1576.

47. Smyth NA, Murawski CD, Fortier LA, Cole BJ, Kennedy JG. Platelet-rich plasma in the pathologic processes of cartilage: Review of basic science evidence. Arthroscopy 2013;29:1399–1409.

48. Marx RE, Carlson ER, Eichstaedt RM, Schimmele SR, Strauss JE, Georgeff KR. Platelet-rich plasma: Growth factor enhancement for bone grafts. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1998;85:638–646.

49. Ono A, Westein E, Hsiao S, et al. Identification of a fibrin-independent platelet contractile mechanism regulating primary hemostasis and thrombus growth. Blood 2008;112:90–99.

50. Cosemans JM, Angelillo-Scherrer A, Mattheij NJ, Heemskerk JW. The effects of arterial flow on platelet activation, thrombus growth, and stabilization. Cardiovasc Res 2013;99:342–352.

51. Karpatkin S. Heterogeneity of human platelets. VI. Correlation of platelet function with platelet volume. Blood 1978;51:307–316.

52. Hartley PS. Platelet senescence and death. Clin Lab 2007;53:157–166.

53. White JG. Electron microscopy methods for studying platelet structure and function. Methods Mol Biol 2004;272:47–63.

54. Coppinger JA, Maguire PB. Insights into the platelet releasate. Curr Pharm Des 2007;13:2640–2646.

55. Bijak M, Saluk J, Ponczek MB, Nowak P, Wachowicz B. The synthesis of proteins in unnucleated blood platelets [in Polish]. Postepy Hig Med Dosw (Online) 2013;67:672–679.

56. Weyrich A, Cipollone F, Mezzetti A, Zimmerman G. Platelets in atherothrombosis: New and evolving roles. Curr Pharm Des 2007;13:1685–1691.

57. Linden MD, Jackson DE. Platelets: Pleiotropic roles in atherogenesis and atherothrombosis. Int J Biochem Cell Biol 2010;42:1762–1766.

58. Schattner M. Platelets and galectins. Ann Transl Med 2014;2:85.

59. Romaniuk MA, Rabinovich GA, Schattner M. Galectins in the regulation of platelet biology. Methods Mol Biol 2015;1207:269–283.

60. Garraud O, Cognasse F. Platelet toll-like receptor expression: The link between “danger” ligands and inflammation. Inflamm Allergy Drug Targets 2010;9:322–333.

61. Nurden AT. Platelets, inflammation and tissue regeneration. Thromb Haemost 2011;105(suppl 1):S13–S33.

62. Goubau C, Buyse GM, Di Michele M, Van Geet C, Freson K. Regulated granule trafficking in platelets and neurons: A common molecular machinery. Eur J Paediatr Neurol 2013;17:117–125.

63. Habets KL, Huizinga TW, Toes RE. Platelets and autoimmunity. Eur J Clin Invest 2013;43:746–757.

64. Koseoglu S, Flaumenhaft R. Advances in platelet granule biology. Curr Opin Hematol 2013;20:464–471.

65. Golebiewska EM, Poole AW. Platelet secretion: From haemostasis to wound healing and beyond. Blood Rev 2015;29:153–162.

66. Duchene J, von Hundelshausen P. Platelet-derived chemokines in atherosclerosis. Hamostaseologie 2015;35:137–141.

67. van den Dolder J, Mooren R, Vloon AP, Stoelinga PJ, Jansen JA. Platelet-rich plasma: Quantification of growth factor levels and the effect on growth and differentiation of rat bone marrow cells. Tissue Eng 2006;12:3067–3073.

68. Nikolidakis D, Jansen JA. The biology of platelet-rich plasma and its application in oral surgery: Literature review. Tissue Eng Part B Rev 2008;14:249–258.